Special Report: The Lab Kickback Risks of “Freebies”
How to avoid six common compliance risks involving free supplies, equipment, software, and other non-monetary compensation
Practical, “What-to-Do” and “How-to-Do-It” Help to Comply with the Latest State & Federal Laws, Rules & Regulations that Affect Your Diagnostic Lab or Pathology Practice
How to avoid six common compliance risks involving free supplies, equipment, software, and other non-monetary compensation
Know where labs may fall foul of compliance requirements—and discover the actions your lab can take to mitigate the risk of noncompliance
Labs that invested heavily in POC molecular tests during COVID-19 are well positioned to leverage this equipment toward GAS diagnostics
Recent enforcement actions and court cases include kickback schemes a-plenty and a reminder to focus on HIPAA compliance
Factors laboratories should consider when evaluating their compliance challenges, needs, and goals to select compliance solutions
New policies aim to better protect data against increasing cyberattacks, but academics say the changes will limit critical research
How widespread is corruption in the lab—and what can be done to combat it?
Though potential FDA LDTs regulation has drawn a lot of attention, other efforts could also have long-term effects on how labs do business.
The ALZpath DX assay is less invasive than other diagnostic tests, and may give patients diagnosed with Alzheimer’s more time to plan
The impending legislation that may determine Medicare lab fees from 2025 onward
Recent enforcement actions include convictions and guilty pleas for false claims-related allegations involving toxicology labs.